Sartorius AG is rebounding with strong bioprocess segment growth and improving profit margins, despite a challenging ...

Company to submit Investigational Device Exemption (IDE) to FDA for novel CBGM technology in Spring 2026Expanded clinical advisory team with ...

Tight valuations persist despite bouts of volatility, with private-credit stresses and weakening growth outlooks leaving markets sensitive to shocks ...

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...

M-$35M in tonneau cover sales, with additional major contributions anticipated from upcoming launches of the SOLIS solar-integrated tonneau cover and COR battery system. West ...

Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced its financial results for the third quarter and provided a business update.

Delivered 130 units and generated $16.5 million in revenueAchieved 15.3% Gross Margin and a second consecutive quarter of positive free cash flow ...

OMER, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (NASDAQ: ODYS), a leading provider of visual based predictive maintenance (PdM) and condition-based monitoring (CBM) solutions, ...

STS-J01 in Japan: In Japan, preliminary results from the investigator-initiated clinical trial (STS-J01) evaluating PEDMARK ® are expected in the fourth quarter of 2025. If the data are positive, the ...

Produced Higher Margins, Lower Operating Expenses, and Significantly Narrowed Losses Compared to Q2 2025 New Product ...

Completed enrollment of the randomized Phase 1b cohorts of the ongoing ENABLE trial of ELVN-001 in CML Remains on track to initiate Phase 3 pivotal trial of ELVN-001 ...